Sign in

    Oddity Tech (ODD)

    ODD Q4 2024: Repeat Sales Top 60% of Revenue, 12-Month Rate >100%

    Reported on Jul 24, 2025 (After Market Close)
    Pre-Earnings Price$45.35Last close (Feb 26, 2025)
    Post-Earnings Price$47.31Open (Feb 27, 2025)
    Price Change
    $1.96(+4.32%)
    • Strong Customer Loyalty: The company’s repeat sales are robust—with a 12-month net revenue repeat rate of over 100% and repeat purchases comprising more than 60% of total revenue—indicating a loyal customer base that supports sustained recurring revenue.
    • Innovative Product Pipeline & Telehealth Expansion: The push into innovative new areas, such as the scheduled soft launch and full rollout of their telehealth platform (Brand 3) and ongoing investments in research and development through Oddity Labs, positions the company to capture new growth opportunities despite near-term margin compression.
    • Accelerated International Expansion: The firm is actively accelerating its growth in international markets by localizing offerings in key regions (e.g., the U.K., Germany, Australia), which could unlock significant revenue opportunities beyond the U.S. market.
    • Margin Pressure from Heavy Growth Investments: The significant capital allocated to new brands (e.g., Brand 3) and Oddity Labs—where early-stage products like the telehealth platform are expected to deliver lower gross margins due to higher cost structures—could pressure short-term profitability.
    • Execution Risks in International Expansion: The deliberate slow ramp-up and testing in international markets pose a risk that localized execution may not replicate domestic performance, potentially delaying expected revenue growth abroad.
    • Vulnerability to Rising Acquisition Costs: The reliance on digital channels, coupled with rising media spending (illustrated by concerns over expensive Q1 customer acquisition and potential platform disruptions like TikTok), may erode margins if new user acquisition costs escalate faster than repeat business improves.
    1. Repeat Performance
      Q: What's the repeat purchase trend?
      A: Management noted that repeat revenue now accounts for over 60% of total business and a 12‑month repeat rate exceeding 100% shows strong customer loyalty and lasting demand.

    2. International Growth
      Q: How is international expansion and Q1 acquisition performing?
      A: They are increasingly expanding into markets like the U.K., Germany, and Australia, and early Q1 results show strong growth driven by improved acquisition metrics and robust repeat behavior.

    3. Customer Mix
      Q: New user versus repeat impact in Q1?
      A: Management emphasized a balanced growth approach with aggressive new user acquisition complemented by a healthy repeat business that bolsters margins.

    4. Brand 3 Milestones
      Q: What milestones drive Brand 3's near-term launch?
      A: Brand 3 is set for a soft launch in Q3 and a full rollout in Q4, underpinned by significant investments in product testing and telehealth capabilities.

    5. Telehealth Margins
      Q: How will telehealth margins affect profits?
      A: While prescription-related fulfillment brings lower margins, high repeat usage and strong unit economics are expected to balance out overall profitability.

    6. Labs Commercialization
      Q: What is the commercialization plan for Oddity Labs?
      A: The company is building a robust commercialization framework, planning multiple product programs that will yield both short-term launches and long-term innovations.

    7. Organic vs M&A
      Q: What is the strategy: organic growth versus M&A?
      A: They are combining internal development with targeted acquisitions—such as the acquisition of Revelo—to effectively double their capacity in key innovation areas.

    8. Brand 3 Details
      Q: What need states and market does Brand 3 target?
      A: Brand 3 focuses on addressing consumer issues like eczema, hyperpigmentation, and body conditions, supported by nearly 100 consumer trial groups that confirmed its efficacy.

    9. Macro & TikTok
      Q: Is consumer weakness or TikTok disruption a risk?
      A: Management reassured that neither deteriorating consumer confidence nor temporary issues with TikTok pose a material threat, citing agile media spend shifts and robust online dynamics.

    10. Product Pipeline
      Q: What new products are launching in Q1 pipeline?
      A: They routinely introduce about 5 new products per brand, with a strong pipeline bolstered by extensive pre-launch testing and innovation efforts.

    11. Consumer Environment
      Q: How resilient is the current consumer market?
      A: Despite broader economic uncertainties, the beauty segment enjoys a resilient consumer base across diverse demographics, driven by strong value propositions.

    12. Cross-Selling
      Q: What is the cross-selling rate between brands?
      A: Approximately 50% of SpoilChild’s revenue is derived from Il Makiage users, underscoring effective brand synergy and customer crossover.

    Research analysts covering Oddity Tech.